ID   CAH3_HUMAN              Reviewed;         260 AA.
AC   P07451; B2R867; B3KUC8; O60842;
DT   01-APR-1988, integrated into UniProtKB/Swiss-Prot.
DT   20-MAR-2007, sequence version 3.
DT   15-MAR-2017, entry version 178.
DE   RecName: Full=Carbonic anhydrase 3;
DE            EC=4.2.1.1;
DE   AltName: Full=Carbonate dehydratase III;
DE   AltName: Full=Carbonic anhydrase III;
DE            Short=CA-III;
GN   Name=CA3;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   PubMed=3086182; DOI=10.1016/0378-1119(86)90103-4;
RA   Lloyd J., McMillan S., Hopkinson D., Edwards Y.H.;
RT   "Nucleotide sequence and derived amino acid sequence of a cDNA
RT   encoding human muscle carbonic anhydrase.";
RL   Gene 41:233-239(1986).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=3099285; DOI=10.1073/pnas.83.24.9571;
RA   Wade R., Gunning P., Eddy R., Shows T., Kedes L.;
RT   "Nucleotide sequence, tissue-specific expression, and chromosome
RT   location of human carbonic anhydrase III: the human CAIII gene is
RT   located on the same chromosome as the closely linked CAI and CAII
RT   genes.";
RL   Proc. Natl. Acad. Sci. U.S.A. 83:9571-9575(1986).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA], AND VARIANT ILE-31.
RC   TISSUE=Pericardium, and Skeletal muscle;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA], AND VARIANT ILE-31.
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA], AND VARIANT ILE-31.
RC   TISSUE=Muscle;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   PARTIAL NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=2824285; DOI=10.1101/gad.1.6.594;
RA   Lloyd J., Brownson C., Tweedie S., Charlton J., Edwards Y.H.;
RT   "Human muscle carbonic anhydrase: gene structure and DNA methylation
RT   patterns in fetal and adult tissues.";
RL   Genes Dev. 1:594-602(1987).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1-11, AND DEVELOPMENTAL STAGE.
RX   PubMed=9651514; DOI=10.1016/S0378-1119(98)00201-7;
RA   Sowden J., Smith H., Morrison K., Edwards Y.;
RT   "Sequence comparisons and functional studies of the proximal promoter
RT   of the carbonic anhydrase 3 (CA3) gene.";
RL   Gene 214:157-165(1998).
RN   [8]
RP   ENZYME REGULATION.
RX   PubMed=19186056; DOI=10.1016/j.bmcl.2009.01.038;
RA   Crocetti L., Maresca A., Temperini C., Hall R.A., Scozzafava A.,
RA   Muehlschlegel F.A., Supuran C.T.;
RT   "A thiabendazole sulfonamide shows potent inhibitory activity against
RT   mammalian and nematode alpha-carbonic anhydrases.";
RL   Bioorg. Med. Chem. Lett. 19:1371-1375(2009).
RN   [9]
RP   ENZYME REGULATION.
RX   PubMed=19206230; DOI=10.1021/ja809683v;
RA   Maresca A., Temperini C., Vu H., Pham N.B., Poulsen S.-A.,
RA   Scozzafava A., Quinn R.J., Supuran C.T.;
RT   "Non-zinc mediated inhibition of carbonic anhydrases: coumarins are a
RT   new class of suicide inhibitors.";
RL   J. Am. Chem. Soc. 131:3057-3062(2009).
RN   [10]
RP   BIOPHYSICOCHEMICAL PROPERTIES, AND ENZYME REGULATION.
RX   PubMed=18618712; DOI=10.1002/prot.22144;
RA   Di Fiore A., Monti S.M., Hilvo M., Parkkila S., Romano V., Scaloni A.,
RA   Pedone C., Scozzafava A., Supuran C.T., De Simone G.;
RT   "Crystal structure of human carbonic anhydrase XIII and its complex
RT   with the inhibitor acetazolamide.";
RL   Proteins 74:164-175(2009).
RN   [11]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [12]
RP   X-RAY CRYSTALLOGRAPHY (2.10 ANGSTROMS) OF 1-260 IN COMPLEX WITH ZINC
RP   ION, MUTAGENESIS OF PHE-197, ACTIVATION BY IMIDAZOLE AND
RP   HISTIDYLHISTIDINE, AND COFACTOR.
RX   PubMed=16042381; DOI=10.1021/bi050610h;
RA   Duda D.M., Tu C., Fisher S.Z., An H., Yoshioka C., Govindasamy L.,
RA   Laipis P.J., Agbandje-McKenna M., Silverman D.N., McKenna R.;
RT   "Human carbonic anhydrase III: structural and kinetic study of
RT   catalysis and proton transfer.";
RL   Biochemistry 44:10046-10053(2005).
RN   [13]
RP   X-RAY CRYSTALLOGRAPHY (1.70 ANGSTROMS) OF 1-260 IN COMPLEX WITH ZINC
RP   ION, MUTAGENESIS OF LYS-64 AND ARG-67, AND COFACTOR.
RX   PubMed=17427958; DOI=10.1002/prot.21403;
RA   Elder I., Fisher Z., Laipis P.J., Tu C., McKenna R., Silverman D.N.;
RT   "Structural and kinetic analysis of proton shuttle residues in the
RT   active site of human carbonic anhydrase III.";
RL   Proteins 68:337-343(2007).
CC   -!- FUNCTION: Reversible hydration of carbon dioxide.
CC   -!- CATALYTIC ACTIVITY: H(2)CO(3) = CO(2) + H(2)O.
CC   -!- COFACTOR:
CC       Name=Zn(2+); Xref=ChEBI:CHEBI:29105;
CC         Evidence={ECO:0000269|PubMed:16042381,
CC         ECO:0000269|PubMed:17427958};
CC   -!- ENZYME REGULATION: Activated by proton donors such as imidazole
CC       and the dipeptide histidylhistidine. Inhibited by coumarins and
CC       sulfonamide derivatives such as acetazolamide.
CC       {ECO:0000269|PubMed:18618712, ECO:0000269|PubMed:19186056,
CC       ECO:0000269|PubMed:19206230}.
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         KM=52.0 mM for CO(2) {ECO:0000269|PubMed:18618712};
CC   -!- SUBCELLULAR LOCATION: Cytoplasm.
CC   -!- TISSUE SPECIFICITY: Muscle specific.
CC   -!- DEVELOPMENTAL STAGE: At 6 weeks gestation, transcripts accumulate
CC       at low levels in the somites and at high levels throughout the
CC       notochord. As gestation continues, CA3 becomes abundant in all
CC       developing muscle masses and continues at high to moderate levels
CC       in the notochord. {ECO:0000269|PubMed:9651514}.
CC   -!- PTM: S-glutathionylated in hepatocytes under oxidative stress.
CC       {ECO:0000250}.
CC   -!- SIMILARITY: Belongs to the alpha-carbonic anhydrase family.
CC       {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; M29458; AAA52293.1; -; Genomic_DNA.
DR   EMBL; M29452; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AK096880; BAG53390.1; -; mRNA.
DR   EMBL; AK313254; BAG36064.1; -; mRNA.
DR   EMBL; CH471068; EAW87133.1; -; Genomic_DNA.
DR   EMBL; BC004897; AAH04897.1; -; mRNA.
DR   EMBL; AJ006473; CAA07056.1; -; Genomic_DNA.
DR   CCDS; CCDS6238.1; -.
DR   PIR; A26658; CRHU3.
DR   RefSeq; NP_005172.1; NM_005181.3.
DR   UniGene; Hs.82129; -.
DR   PDB; 1Z93; X-ray; 2.10 A; A=1-260.
DR   PDB; 1Z97; X-ray; 2.10 A; A=1-260.
DR   PDB; 2HFW; X-ray; 2.50 A; A=1-259.
DR   PDB; 3UYN; X-ray; 2.60 A; A=1-260.
DR   PDB; 3UYQ; X-ray; 1.70 A; A=1-260.
DR   PDBsum; 1Z93; -.
DR   PDBsum; 1Z97; -.
DR   PDBsum; 2HFW; -.
DR   PDBsum; 3UYN; -.
DR   PDBsum; 3UYQ; -.
DR   ProteinModelPortal; P07451; -.
DR   SMR; P07451; -.
DR   BioGrid; 107216; 2.
DR   IntAct; P07451; 1.
DR   STRING; 9606.ENSP00000285381; -.
DR   BindingDB; P07451; -.
DR   ChEMBL; CHEMBL2885; -.
DR   DrugBank; DB00819; Acetazolamide.
DR   DrugBank; DB08846; Ellagic Acid.
DR   DrugBank; DB00909; Zonisamide.
DR   iPTMnet; P07451; -.
DR   PhosphoSitePlus; P07451; -.
DR   BioMuta; CA3; -.
DR   DMDM; 134047703; -.
DR   UCD-2DPAGE; P07451; -.
DR   EPD; P07451; -.
DR   PaxDb; P07451; -.
DR   PeptideAtlas; P07451; -.
DR   PRIDE; P07451; -.
DR   DNASU; 761; -.
DR   Ensembl; ENST00000285381; ENSP00000285381; ENSG00000164879.
DR   GeneID; 761; -.
DR   KEGG; hsa:761; -.
DR   CTD; 761; -.
DR   DisGeNET; 761; -.
DR   GeneCards; CA3; -.
DR   H-InvDB; HIX0078885; -.
DR   HGNC; HGNC:1374; CA3.
DR   HPA; CAB004967; -.
DR   HPA; HPA021775; -.
DR   HPA; HPA026700; -.
DR   MIM; 114750; gene.
DR   neXtProt; NX_P07451; -.
DR   OpenTargets; ENSG00000164879; -.
DR   PharmGKB; PA25990; -.
DR   eggNOG; KOG0382; Eukaryota.
DR   eggNOG; COG3338; LUCA.
DR   GeneTree; ENSGT00760000118915; -.
DR   HOGENOM; HOG000112637; -.
DR   HOVERGEN; HBG002837; -.
DR   InParanoid; P07451; -.
DR   KO; K01672; -.
DR   OMA; KQRDGIA; -.
DR   OrthoDB; EOG091G0XFM; -.
DR   PhylomeDB; P07451; -.
DR   TreeFam; TF316425; -.
DR   BRENDA; 4.2.1.1; 2681.
DR   Reactome; R-HSA-1475029; Reversible hydration of carbon dioxide.
DR   EvolutionaryTrace; P07451; -.
DR   GeneWiki; Carbonic_anhydrase_III,_muscle_specific; -.
DR   GenomeRNAi; 761; -.
DR   PRO; PR:P07451; -.
DR   Proteomes; UP000005640; Chromosome 8.
DR   Bgee; ENSG00000164879; -.
DR   CleanEx; HS_CA3; -.
DR   ExpressionAtlas; P07451; baseline and differential.
DR   Genevisible; P07451; HS.
DR   GO; GO:0005829; C:cytosol; TAS:Reactome.
DR   GO; GO:0004089; F:carbonate dehydratase activity; TAS:Reactome.
DR   GO; GO:0016151; F:nickel cation binding; IEA:Ensembl.
DR   GO; GO:0016791; F:phosphatase activity; IEA:Ensembl.
DR   GO; GO:0008270; F:zinc ion binding; IEA:InterPro.
DR   GO; GO:0015701; P:bicarbonate transport; TAS:Reactome.
DR   GO; GO:0006730; P:one-carbon metabolic process; IEA:InterPro.
DR   GO; GO:0045471; P:response to ethanol; IEA:Ensembl.
DR   GO; GO:0006979; P:response to oxidative stress; IEA:Ensembl.
DR   Gene3D; 3.10.200.10; -; 1.
DR   InterPro; IPR001148; Carbonic_anhydrase_a.
DR   InterPro; IPR023561; Carbonic_anhydrase_a-class.
DR   InterPro; IPR018338; Carbonic_anhydrase_a-class_CS.
DR   InterPro; IPR018441; Carbonic_anhydrase_CA3.
DR   PANTHER; PTHR18952; PTHR18952; 1.
DR   PANTHER; PTHR18952:SF154; PTHR18952:SF154; 1.
DR   Pfam; PF00194; Carb_anhydrase; 1.
DR   SMART; SM01057; Carb_anhydrase; 1.
DR   SUPFAM; SSF51069; SSF51069; 1.
DR   PROSITE; PS00162; ALPHA_CA_1; 1.
DR   PROSITE; PS51144; ALPHA_CA_2; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Complete proteome; Cytoplasm;
KW   Glutathionylation; Lyase; Metal-binding; Phosphoprotein; Polymorphism;
KW   Reference proteome; Zinc.
FT   INIT_MET      1      1       Removed. {ECO:0000250|UniProtKB:P07450}.
FT   CHAIN         2    260       Carbonic anhydrase 3.
FT                                /FTId=PRO_0000077426.
FT   DOMAIN        3    259       Alpha-carbonic anhydrase.
FT                                {ECO:0000255|PROSITE-ProRule:PRU01134}.
FT   REGION       64     67       Involved in proton transfer.
FT   REGION      198    199       Substrate binding.
FT                                {ECO:0000250|UniProtKB:P00918}.
FT   ACT_SITE    127    127       {ECO:0000250|UniProtKB:P00918}.
FT   METAL        94     94       Zinc; catalytic.
FT                                {ECO:0000269|PubMed:16042381,
FT                                ECO:0000269|PubMed:17427958}.
FT   METAL        96     96       Zinc; catalytic.
FT                                {ECO:0000269|PubMed:16042381,
FT                                ECO:0000269|PubMed:17427958}.
FT   METAL       119    119       Zinc; catalytic.
FT                                {ECO:0000269|PubMed:16042381,
FT                                ECO:0000269|PubMed:17427958}.
FT   MOD_RES       2      2       N-acetylalanine.
FT                                {ECO:0000250|UniProtKB:P07450}.
FT   MOD_RES      29     29       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:P14141}.
FT   MOD_RES      43     43       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:P14141}.
FT   MOD_RES      48     48       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:P14141}.
FT   MOD_RES      50     50       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:P14141}.
FT   MOD_RES      55     55       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:P14141}.
FT   MOD_RES      73     73       Phosphothreonine.
FT                                {ECO:0000250|UniProtKB:P14141}.
FT   MOD_RES     127    127       Phosphotyrosine.
FT                                {ECO:0000250|UniProtKB:P14141}.
FT   MOD_RES     129    129       Phosphothreonine.
FT                                {ECO:0000250|UniProtKB:P14141}.
FT   MOD_RES     176    176       Phosphothreonine.
FT                                {ECO:0000250|UniProtKB:P16015}.
FT   MOD_RES     182    182       S-glutathionyl cysteine. {ECO:0000250}.
FT   MOD_RES     187    187       S-glutathionyl cysteine. {ECO:0000250}.
FT   MOD_RES     216    216       Phosphothreonine.
FT                                {ECO:0000250|UniProtKB:P14141}.
FT   MOD_RES     219    219       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:P14141}.
FT   VARIANT      31     31       V -> I (in dbSNP:rs20571).
FT                                {ECO:0000269|PubMed:14702039,
FT                                ECO:0000269|PubMed:15489334,
FT                                ECO:0000269|Ref.4}.
FT                                /FTId=VAR_016180.
FT   MUTAGEN      64     64       K->H: Enhanced proton transfer in
FT                                catalysis. {ECO:0000269|PubMed:17427958}.
FT   MUTAGEN      67     67       R->H: Enhanced proton transfer in
FT                                catalysis. {ECO:0000269|PubMed:17427958}.
FT   MUTAGEN     197    197       F->L: Enhanced activity by at least 10-
FT                                fold. {ECO:0000269|PubMed:16042381}.
FT   TURN          9     11       {ECO:0000244|PDB:3UYQ}.
FT   TURN         13     15       {ECO:0000244|PDB:3UYQ}.
FT   HELIX        16     18       {ECO:0000244|PDB:3UYQ}.
FT   HELIX        21     24       {ECO:0000244|PDB:3UYQ}.
FT   STRAND       25     27       {ECO:0000244|PDB:2HFW}.
FT   HELIX        35     37       {ECO:0000244|PDB:3UYQ}.
FT   STRAND       47     50       {ECO:0000244|PDB:3UYQ}.
FT   HELIX        53     55       {ECO:0000244|PDB:3UYQ}.
FT   STRAND       56     61       {ECO:0000244|PDB:3UYQ}.
FT   STRAND       66     70       {ECO:0000244|PDB:3UYQ}.
FT   STRAND       73     75       {ECO:0000244|PDB:3UYQ}.
FT   STRAND       77     81       {ECO:0000244|PDB:3UYQ}.
FT   STRAND       88     97       {ECO:0000244|PDB:3UYQ}.
FT   STRAND      106    109       {ECO:0000244|PDB:3UYQ}.
FT   STRAND      115    123       {ECO:0000244|PDB:3UYQ}.
FT   HELIX       125    127       {ECO:0000244|PDB:3UYQ}.
FT   HELIX       130    133       {ECO:0000244|PDB:3UYQ}.
FT   STRAND      139    151       {ECO:0000244|PDB:3UYQ}.
FT   HELIX       154    160       {ECO:0000244|PDB:3UYQ}.
FT   HELIX       161    165       {ECO:0000244|PDB:3UYQ}.
FT   STRAND      172    174       {ECO:0000244|PDB:3UYQ}.
FT   HELIX       180    183       {ECO:0000244|PDB:3UYQ}.
FT   STRAND      190    195       {ECO:0000244|PDB:3UYQ}.
FT   STRAND      206    213       {ECO:0000244|PDB:3UYQ}.
FT   STRAND      215    217       {ECO:0000244|PDB:3UYQ}.
FT   HELIX       219    225       {ECO:0000244|PDB:3UYQ}.
FT   STRAND      229    231       {ECO:0000244|PDB:3UYQ}.
FT   STRAND      233    236       {ECO:0000244|PDB:3UYQ}.
FT   STRAND      256    258       {ECO:0000244|PDB:3UYQ}.
SQ   SEQUENCE   260 AA;  29557 MW;  A305334167233FCF CRC64;
     MAKEWGYASH NGPDHWHELF PNAKGENQSP VELHTKDIRH DPSLQPWSVS YDGGSAKTIL
     NNGKTCRVVF DDTYDRSMLR GGPLPGPYRL RQFHLHWGSS DDHGSEHTVD GVKYAAELHL
     VHWNPKYNTF KEALKQRDGI AVIGIFLKIG HENGEFQIFL DALDKIKTKG KEAPFTKFDP
     SCLFPACRDY WTYQGSFTTP PCEECIVWLL LKEPMTVSSD QMAKLRSLLS SAENEPPVPL
     VSNWRPPQPI NNRVVRASFK
//
